$5 And Under


Shares of Altimmune Inc. (ALT), a clinical-stage biopharmaceutical company, are currently up a whopping 120 percent, following news that the Company has completed the design and synthesis of the vaccine against COVID-19 and is now advancing it toward animal testing and manufacturing.

Shares of Happiness Biotech Group Limited (HAPP) have gained over 13 percent ever since the Company's official entry into the disinfectant industry on Feb.25, 2020.

Shares of IMV Inc. (IMV) have gained more than 20 percent over the last 5 trading days as the Company gears up to report topline results from its DeCidE1 trial on February 25, 2020.

Genprex, Inc. (GNPX) is currently trading at $1.60, an increase of 29 percent from the previous closing price of $1.24, following an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes.

Follow RTT